If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Aug 2013 08:34

RNS Number : 7660L
Byotrol PLC
15 August 2013
 



Byotrol plc

(the "Company")

Director's Holdings in Company

Further to the announcements made on 9 and 13 August 2013, Byotrol plc was notified on 14 August 2013 that on that date Maunby Investment Management Ltd ("Maunby") disposed of a further 400,000 ordinary shares of 0.25p each in the capital of the Company ("Ordinary Shares").

This disposal was also on behalf of Fund JF1, a fund administered by Jervaulx Capital ("Jervaulx"). The Company understands that this transaction concludes the disposals by Fund JF1. Nicholas Martel, non-executive director of Byotrol, has a controlling interest in Jervaulx but is not a director of Jervaulx.

Following this latest transaction, Maunby now holds 24,599,709 Ordinary Shares representing 16.5 per cent of the Company's issued share capital.

Accordingly, following this transaction, Nicholas Martel has a personal beneficial interest in 1,000,000 Ordinary Shares equating to 0.7 per cent. of the Company's issued share capital. Mr Martel also has a non-beneficial interest in 17,693,513 Ordinary Shares equating to 11.8 per cent of the Company's issued share capital.

Enquiries:

 

Byotrol plc

01925 742000

Ralph Kugler, Chairman

 

Gary Millar, Chief Executive

 

Duncan Grosvenor, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Nominated Adviser and broker

 

Geoff Nash/Christopher Raggett

Simon Starr (Corporate Broking)

 

 

 

Winningtons

020 3176 4722

Tom Cooper / Paul Vann

0797 122 1972

 

tom.cooper@winningtons.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMGMRNKZGFZG
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.